Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
140.77B
Market cap140.77B
Price-Earnings ratio
13.16
Price-Earnings ratio13.16
Dividend yield
6.91%
Dividend yield6.91%
Average volume
36.43M
Average volume36.43M
High today
$24.88
High today$24.88
Low today
$24.51
Low today$24.51
Open price
$24.68
Open price$24.68
Volume
37.03M
Volume37.03M
52 Week high
$30.43
52 Week high$30.43
52 Week low
$20.92
52 Week low$20.92

PFE News

TipRanks 1d
Mixed options sentiment in Pfizer with shares up 0.63%

Mixed options sentiment in Pfizer (PFE), with shares up 16c, or 0.63%, near $24.75. Options volume relatively light with 61k contracts traded and calls leading...

TipRanks 3d
FDA Approves BioNTech and Pfizer’s New COVID-19 Vaccine for High-Risk Groups

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Benzinga 3d
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines

Health and Human Services Secretary Robert F. Kennedy Jr. announced on social media that the emergency use authorizations for COVID-19 vaccines have now been re...

RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines

Analyst ratings

64%

of 25 ratings
Buy
32%
Hold
64%
Sell
4%

More PFE News

TipRanks 3d
Pfizer, BioNTech announce FDA approval for sBLA for COVID-19 vaccine

Pfizer (PFE) and BioNTech SE (BNTX) announced the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the companie...

Benzinga 5d
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'

The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market "within months," according to a close associate of Health and Human Servi...

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'
Simply Wall St 6d
Pfizer Valuation in Focus After EU Patent Lawsuit Threatens Paxlovid Revenue Streams

Advertisement Most Popular Narrative: 15.5% Undervalued If you’ve been watching Pfizer (PFE) lately, the latest legal action from Enanta Pharmaceuticals may h...

Pfizer Valuation in Focus After EU Patent Lawsuit Threatens Paxlovid Revenue Streams

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.